LeadInvent is an integrated drug discovery company working at the fore front of bringing newer treatment options to patients in oncology and mens's health. The start up which incubated from IIT-Delhi, has recently made it to CIO Review magazine's top list of promising pharma and life sciences technology solution providers.

CIO Review has chosen LeadInvent for its 20 most promising pharma and life sciences technology solution providers in 2015. The positioning is based on LeadInvent's core technology and scientific team that allows for rapid drug development with rational approach. The annual list of companies is selected by a panel of experts and members of magazine's editorial board to recognize and promote technology entrepreneurship.

The team  at LeadInvent comprises of scientists and business leaders with extensive experience in pharma and drug development space. Earlier it was awarded as Asia Pacific Emerging Company of the Year 2011 by the BioSpectrum. It has worked with multiple partners from India and abroad.

The company has received multiple grants from the government of India and has developed unique molecule simulation technology platform that allows the team to rationally design new molecules with minimum hit and trials. LeadInvent leverages nano technology making existing drugs more safe with better efficacy providing a unique blend of innovation and treatment options for patients.